Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04106193 · ClinicalTrials.gov registry record · NA
Addressing Intimate Partner Violence Among Women Veterans
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 7,421
- Enrollment target
NCT04106193: Completed NA study, sponsored by VA Office of Research and Development.
NCT04106193 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 7,421 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (429% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04106193, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,421 participants
- Enrollment target
Study Summary
Up to 20% of women Veterans (WV) using VHA primary care experience past-year intimate partner violence (IPV), which contributes to numerous physical and mental health conditions, including suicidality. Despite national recommendations to screen WVs for IPV, there is low adoption of IPV screening programs in primary care. In response, VHA is spreading IPV screening programs in Women's Health Model 1 and Model 2 primary care clinics, where the majority of WV VHA primary care patients receive care. The systematic and effective implementation of IPV screening programs within primary care clinics is expected to enhance care for WVs as well as improve access to, and timeliness of, IPV-related care. Given the high prevalence of IPV among WVs and its significant negative health effects, successful implementation of IPV screening programs is expected to reduce morbidity among WV VHA patients. This stepped wedge hybrid II implementation/effectiveness study will assess efforts to implement routine IPV screening for WV VHA patients.
Primary Outcome
Change in proportion of WVs seen in Model 1 and 2 clinics during the last three months of each study phase who receive IPV screening
Interventions
- OTHER Blended Facilitation
- OTHER Implementation as usual
- OTHER Toolkit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,421 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
What the finished NCT04106193 record still lists
NCT04106193 is an interventional study that assigns participants to a tested intervention. Its 7,421 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (429% higher).
The record links to 0 conditions, and to 3 interventions - of which Blended Facilitation is the first listed.
NCT04106193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04106193 about?
NCT04106193 is a clinical study titled "Addressing Intimate Partner Violence Among Women Veterans". Up to 20% of women Veterans (WV) using VHA primary care experience past-year intimate partner violence (IPV), which contributes to numerous physical and mental health conditions, including suicidality. Despite national recommendations to screen WVs for IPV, there is low adoption of IPV screening pro...
What is the current status of trial NCT04106193?
This trial is currently completed. It is a NA study. The enrollment target is 7,421 participants. The study started on 2020-11-01. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT04106193?
The interventions under investigation include: Blended Facilitation (OTHER), Implementation as usual (OTHER), Toolkit (OTHER).
Who is sponsoring clinical trial NCT04106193?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04106193's enrollment target sits among peer trials
7,421 20th of 2000 higher than 1,981 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02915198 · 7,410 participants · Phase 4
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
- NCT05199701 · 7,500 participants · NA
Prospective Case Collection Study for New Mammography Technologies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI